ROLE OF LEVOFLOXACIN FOR TREATMENT OF CHRONIC SUPPURATIVE OTITIS MEDIA: SAMPLE OF IRAQI PATIENTS
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i9.18147Keywords:
Otitis media, Levofloxacin, FluoroquinoloneAbstract
Â
 Objective: To evaluate levofloxacin efficiency for treatment of chronic suppurative otitis media in sample of Iraqi patients.
Methods: This is a prospective study which includes 50 patients of different age groups diagnosed with CSOM. Aural toilet and otosporin ear drop performed in clinic, then levofloxacin prescribed as single oral tablet daily for 4-6 weeks. Patients were examined every 2 weeks for 8 weeks and then once by month for 6 months to evaluate the efficiency of treatment.
Results: Forty patients (80%) showed complete dryness and healing. Discharge decreased upon the visits with more dryness observed after 4 weeks of treatment. Signs of healing and tympanic perforation closure apparently occur about 1 month from the initial treatment in 32 patients (80% of successful treatment). Culture sensitivity tests results were Pseudomonas aeruginosa and Klebsiella species in discharge materials.
Conclusion: Levofloxacin is a safe and effective drug for the treatment of CSOM and promising treatment for CSOM in combination with aural toilet. The main species of microorganism detected were P. aeruginosa and Klebsiella.
Downloads
References
Kenna MA. Treatment of chronic suppurative otitis media. Otolaryngol Clin North Am 1994;27:457-72.
Goycoolea MV, Hueb MM, Ruah C. Otitis media: The pathogenesis approach. Definitions and terminology. Otolaryngol Clin North Am 1991;24:757-61.
Verhoeff M, van der Veen EL, Rovers MM, Sanders EA, Schilder AG. Chronic suppurative otitis media: A review. Int J Pediatr Otorhinolaryngol 2006;70:1-12.
MacIntyre EA, Heinrich J. Otitis media in infancy and the development of asthma and atopic disease. Curr Allergy Asthma Rep 2012;12(6):547-50.
Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M. Update on otitis media – prevention and treatment. Infect Drug Resist 2014;7:15-24.
Berlin IL. Chronic Suppurative Otitis Media: Burden of Illness and Management Options. Geneva, Switzerland: World Health Organization; 2004.
Reiss M, Reiss G. Suppurative chronic otitis media: Etiology, diagnosis and therapy. Med Monatsschr Pharm 2010;33:11-6.
Neeraja P, Parthasarathy T, Sudhakar M. Evaluation of different culture media for enhanced production of Pseudomonas aeruginosa (MTCC NO 2453) biomass and its proteins. Int J Pharm Pharm Sci 2016;8(11):120-3.
Miro N, Perello E, Casamitjana F, The Spanish ENT Study Group Affiliation: From the Servicio de OtorrinolaringologıÌa, Hospital Universitario Germans Trias i Pujol. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Otolaryngol Head Neck Surg 2000;23:617-23.
Macfadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev 2006;1:25.
Mishiro Y, Sakagami M, Takahashi Y, Kitahara T, Kajikawa H, Kubo T. Tympanoplasty with and without mastoidectomy for non-cholesteatomatous chronic otitis media. Eur Arch Otorhinolaryngol 2001;258:13-5.
Sharma K, Aggarwal A, Khurana PM. Comparison of bacteriology in bilaterally discharging ears in chronic suppurative otitis media. Indian J Otolaryngol Head Neck Surg 2010;62:153-7.
Ikeda K, Misawa S, Kusunoki T. Comparative bactericidal activity of four fluoroquinolones against Pseudomonas aeruginosa isolated from chronic suppurative otitis media. BMC Ear Nose Throat Disord 2015;15:5.
Pham L, Christensen JM, Rodriguez-Proteau R. Pharmacokinetic prediction of levofloxacin accumulation in tissue and its association to tendinopathy. Pharmacol Pharm 2013;4:121-31.
Katzung BG, Trevor AJ. Basic and Clinical Pharmacology. 13th ed. Norwalk: McGraw-Hill Education; 2015. p. 1116-7.
Berlin IL. Chronic Suppurative Otitis Media: Burden of Illness and Management Options. Geneva, Switzerland: World Health Organization; 2004.
Rotimi VO, Olabiyi DA, Banjo TO, Okeowo PA. Randomised comparative efficacy of clindamycin, metronidazole, and lincomycin, plus gentamicin in chronic suppurative otitis media. West Afr J Med 1990;9:89-97.
Rath S, Das SR, Padhy RN. Surveillance of bacteria Pseudomonas aeruginosa and MRSA associated with chronic suppurative otitis media. Braz J Otorhinolaryngol 2017;83:201-6.
Renukananda GS, Santosh UP, George NM. Topical vs. Combination ciprofloxacin in the management of discharging chronic suppurative otitis media. J Clin Diagn Res 2014;8:KC01-4.
Hwang JH, Lee JH, Hwang JH, Chung KM, Lee EJ, Yoon YJ, et al. Comparison of arbekacin and vancomycin in treatment of chronic suppurative otitis media by methicillin resistant Staphylococcus aureus. J Korean Med Sci 2015;30:688-93.
Lubasch A, Keller I, Borner K, Koeppe P, Lode H. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother 2000;44:2600-3.
Daly KA, Pirie PL, Rhodes KL, Hunter LL, Davey CS. Early otitis media among Minnesota American Indians: The Little Ears Study. Am J Public Health 2007;97:317-22.
Zhang Y, Xu M, Zhang J, Zeng L, Wang Y, Zheng QY. Risk factors for chronic and recurrent otitis media-a meta-analysis. PLoS One 2014;9:e86397.
Ramanna MK, Ruckmani A, Janti SS, Eerike M, Prabu RL. Burden of therapy in patients suffering from diabetes mellitus and hypertension. Int J Pharm Pharm Sci 2017;9(5):210-5.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
